VITEK 2 Systems and VITEK 2 with MYLA.
Published May 18, 2022 · Recall initiated: March 29, 2022
Summary
FDA records medical device Class II recall Z-1059-2022, published May 18, 2022 and initiated March 29, 2022. Recalling firm: bioMerieux, Inc.; Status: Ongoing; Reported quantity: 21,757 systems; Lot: VITEK 2 - Versions 8.01, 9.01, 9.02 (with or without 9MR2), 9.03 (with or without #9MR2). VITEK 2 with MYLA - Versions 4.8 and 4.9. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Software issue where results sent to the LIS via HL7 format for antibiotic screen tests and synergy tests do not include the user-corrected or AES-corrected interpretation. This can potentially lead to incorrect final screen/synergy test results at the LIS.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- bioMerieux, Inc.
- Distributor
- U.S. distribution of the FSCA to NC. OUS distribution of the FSCA to subsidiaries in Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Egypt, Finland, France, Germany, Greece, Hungary, India, Italy, Japan, Mexico, Netherlands, Norway, Philippines, Poland, Portugal, Russia, Serbia, Sweden, Singapore, South Africa, South Korea, Spain, Switzerland, Thailand, Turkey, and United Kingdom.
- Lot
- VITEK 2 - Versions 8.01, 9.01, 9.02 (with or without 9MR2), 9.03 (with or without #9MR2). VITEK 2 with MYLA - Versions 4.8 and 4.9.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAProterixBio SARS-CoV-2 (RBD) IgG Antibody Test, and associated ProterixBio Dried Blood Spot Collection Kit, noMay 18, 2022
- FDACYSTO-URETHRO-FIBERSCOPE REF 11272C1 CYSTOSCOPE, 15FR X 370MM, ADULT REF 11272C2 and Kit Number 11272CK2May 18, 2022
- FDAVIDAS RUB IgG (RBG), REF 30226January 5, 2022
- FDAVITEK® 2 Systems Software Version 9.01 Update Kit.December 26, 2018
- FDABACT/ALERT VIRTUO system, B Unit, with Version R2.0 Firmware Product Usage: The BacT/ALERT VIRTU MicrobialOctober 31, 2018
- FDAVITEK(R) 2 AST-P655, For susceptibility testing of Staphylococcus spp. Enterococcus spp., ad S agalactiaeSeptember 26, 2018
Questions about this recall
Was VITEK 2 Systems and VITEK 2 with MYLA. recalled?
Yes. FDA published recall Z-1059-2022 on May 18, 2022. Reported hazard: Software issue where results sent to the LIS via HL7 format for antibiotic screen tests and synergy tests do not include the user-corrected or AES-corrected interpretation. This can potentially lead to incorrect final screen/synergy test results at the LIS.
What should I do if I have this product?
Voluntary: Firm initiated · Letter